Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B5FZ
|
||||
Former ID |
DAP001463
|
||||
Drug Name |
Cefozopran
|
||||
Synonyms |
CZOP; Cefozopran [INN]; SCE 2787; Cefozopran (INN); (-)-1-(((6R,7R)-7-(2-(5-Amino-1,2,4-thiadiazol-3-yl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1H-imidazo(1,2-b)pyridazin-4-ium hydroxide inner salt, 7(sup 2)-(Z)-(O-methyloxime); Imidazo(1,2-b)pyridazinium, 1-((6R,7R)-7-(((2Z)-(5-amino-1,2,4-thiadiazol-3-yl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Gram-positive bacterial infection [ICD9:] | Approved | [536094] | ||
Company |
Takeda
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H17N9O5S2
|
||||
Canonical SMILES |
CON=C(C1=NSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)CN4C=C[N+]<br />5=C4C=CC=N5)C(=O)[O-]
|
||||
InChI |
1S/C19H17N9O5S2/c1-33-24-11(14-23-19(20)35-25-14)15(29)22-12-16(30)28-13(18(31)32)9(8-34-17(12)28)7-26-5-6-27-10(26)3-2-4-21-27/h2-6,12,17H,7-8H2,1H3,(H3-,20,22,23,25,29,31,32)/b24-11-/t12-,17-/m1/s1
|
||||
InChIKey |
QDUIJCOKQCCXQY-WHJQOFBOSA-N
|
||||
CAS Number |
CAS 113359-04-9
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
SuperDrug ATC ID |
J01DE03
|
||||
Target and Pathway | |||||
Target(s) | Dihydropteroate synthetase | Target Info | Inhibitor | [536094] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.